UTSWTxID

Interested in learning about the cutting edge in management of infections in HCT, CAR-T, and SOT recipients? Pls mark your calendars for May 11-14, 2025, for the 5th symposium on infections in immunocompromised individuals. Travel stipends available! bit.ly/4hgyLwS

More pearls from @masumi_ueda @fredhutch on Stem Cell Procurement, Conditioning Regimen, and TBI!

Today, you are in for a treat @masumi_ueda @fredhutch is presenting Allogeneic Hematopoietic Cell Transplantation at our Transplant Infectious Diseases Lecture Series! We are so lucky!

@HIVDocSK Congratulations friend! 🎉 🎊🎈

An amazing tag-team presentation on cutting edge management of AML and ALL from @madanatyazan and @VIrizarryGatell for our Transplant ID lecture series! @RicardoLaHozMD @chrislarsenmd @VBeechar @Hanineelhaddad

Great update on all things CMV in TxID from our own Dr Larsen @UTSWMedCenter Good work happening in our @UTSWTxID team! @RicardoLaHozMD @chrislarsenmd @KottonNelson @VBeechar @Hanineelhaddad @ChongPearlie

AJT Highlights September 2024 episode is now live! Check it out for a great selection of articles and a special focus on virus-specific T-cell therapy: ajthighlights.podbean.com/e/ajt-septembe…🌟 #TCellTherapy @AjtHighlights @amjtransplant @JoshLevitskyMD @mannonmom @UTSWTxID @UTSWNephrology

Good morning #TXID! @RicardoLaHozMD continues our Transplant ID lecture series with an illuminating talk on Donor Derived Infections and the challenges of donor call!

Today, in our #TxID lecture Series, we have @Hanineelhaddad. She is dropping important pearls on the management of the hematologic stem cell transplant and CAR-T recipient. We are soooo lucky! @chrislarsenmd @BradCutrellMD @UTSWInfDis @EmilyWongID

We’re thrilled to introduce @EmilyWongID , our #TxID Fellow, for the 2024-2025 Academic Year! Give her a follow! @chrislarsenmd @RicardoLaHozMD @BradCutrellMD @TxID_Fellows @AST_IDCOP @MaryjaneFarrMD

Today our Associate Program Director @chrislarsenmd is celebrating his birthday! 🎂 Say hi to him! @AST_IDCOP

Superstar @VBeechar is joining our program! He is presenting - Evaluating Real World Experience Using Maribavir for R/R CMV in Kidney Transplant Recipients @AST_IDCOP

Bookmark this one! Outstanding talk by @monicaslavin @AST_IDCOP

There is a a potential association between Check Point Inhibitors and rejection in SOT in the available preliminary data?@AST_IDCOP

Oncogenic viruses associated with malignancy in SOT @AST_IDCOP

Next Up @monicaslavin - Addressing unique infections risks with specific cancer chemo therapies in SOT with malignancy!

Include Immune Mimickers in patients on Checkpoint Inhibitors @AST_IDCOP @TxID_Fellows

How Do You Handle Infection in the Immunocompromised Transplant Patient Who Becomes Even More Immunocompromised? @ArunaSubraman12 providing pearls on JAK inhibitors @AST_IDCOP

Run to Level 1 ABC 118 Respiratory Viruses in Transplantation: What Every Transplant Provider Needs to Know - Staring Now @AST_IDCOP